The group's principle activity is to provide access site management products to address the problem of vascular closure during interventional and diagnostic procedures. The group's products include Mynx vascular closure device that seals the arteriotomy using a conformable, water-soluble, and extravascular sealant, which expands in the tissue tract by absorbing blood and subcutaneous fluids. The group operates from United States.
